Stonepine Capital Management LLC 13D and 13G filings for CTI BioPharma Corp.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-04-14 08:25 am Purchase | 2023-04-04 | 13G | CTI BioPharma Corp. CTIC | Stonepine Capital Management LLC | 7,018,046 5.300% | 1,353,946 (+23.90%) | Filing |
| 2023-02-13 10:27 am Sale | 2022-12-31 | 13G | CTI BioPharma Corp. CTIC | Stonepine Capital Management LLC | 5,664,100 4.500% | -4,090,835 (-41.94%) | Filing |
| 2022-02-11 7:06 pm Purchase | 2021-12-31 | 13G | CTI BioPharma Corp. CTIC | Stonepine Capital Management LLC | 9,754,935 9.990% | 1,606,515 (+19.72%) | Filing |
| 2021-02-12 4:26 pm Purchase | 2020-12-31 | 13G | CTI BioPharma Corp. CTIC | Stonepine Capital Management LLC | 8,148,420 9.990% | 4,534,820 (+125.49%) | Filing |